DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019

On September 6, 2019 DiaMedica Therapeutics Inc. (Nasdaq: DMAC) reported that management will attend the Lake Street Capital Markets 3rd Annual Best Ideas Growth (BIG3) Conference on Thursday, September 12th, 2019, at the Parker New York in New York City (Press release, DiaMedica, SEP 6, 2019, View Source [SID1234539347]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

DiaMedica’s President and Chief Executive Officer, Rick Pauls, is scheduled to meet with investors on Thursday, September 12th, with one-on-one meetings to be held throughout the day.

About the BIG3 Conference
Lake Street will host its third annual B.I.G. (Best Ideas Growth) institutional investor conference at the Parker New York, showcasing many interesting, dynamic public growth companies. Executives from approximately 65 publicly traded companies will meet institutional investors in an interactive, one-on-one meeting format. This is an invitation-only event attended by top institutional investors from across the country.

For more information, visit View Source or contact your Lake Street representative or email [email protected].